BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 8824564)

  • 1. Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes.
    Uchida T; Takahashi K; Tatsuno K; Dhingra U; Eliason JF
    Int J Cancer; 1996 Sep; 67(6):892-7. PubMed ID: 8824564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of hepatitis B virus X gene on p21(WAF1) expression through p53-dependent and p53-independent pathways].
    Lin J; Zhu MH; Qu JH; Li FM; Ni CR
    Ai Zheng; 2004 Jul; 23(7):749-55. PubMed ID: 15248906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.
    Huo TI; Wang XW; Forgues M; Wu CG; Spillare EA; Giannini C; Brechot C; Harris CC
    Oncogene; 2001 Jun; 20(28):3620-8. PubMed ID: 11439325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
    Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL
    J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
    Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D
    Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interaction effect of p53 with HBV in hepatoma cell line SMMC-7721].
    Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):403-5. PubMed ID: 15268803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
    Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC
    Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B Virus Core Promoter A1762T/G1764A (TA)/T1753A/T1768A Mutations Contribute to Hepatocarcinogenesis by Deregulating Skp2 and P53.
    Yan J; Yao Z; Hu K; Zhong Y; Li M; Xiong Z; Deng M
    Dig Dis Sci; 2015 May; 60(5):1315-24. PubMed ID: 25567052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma.
    Tang S; Hu W; Hu J; Wu S; Li J; Luo Y; Cao M; Zhou H; Jiang X
    Liver Int; 2015 Feb; 35(2):608-19. PubMed ID: 24423280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transactivation of human alpha-fetoprotein gene by X-gene product of hepatitis B virus in human hepatoma cells.
    Arima T; Nakao K; Nakata K; Ishikawa H; Ichikawa T; Hamasaki K; Ishii N; Eguchi K
    Int J Mol Med; 2002 Apr; 9(4):397-400. PubMed ID: 11891535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
    Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
    World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation.
    Qiu X; Zhang L; Lu S; Song Y; Lao Y; Hu J; Fan H
    Oncol Rep; 2014 Jan; 31(1):202-8. PubMed ID: 24247422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus X protein induces the histone H3 lysine 9 trimethylation on the promoter of p16 gene in hepatocarcinogenesis.
    Wang DY; Zou LP; Liu XJ; Zhu HG; Zhu R
    Exp Mol Pathol; 2015 Dec; 99(3):399-408. PubMed ID: 26341139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus X protein inhibits nucleotide excision repair.
    Jia L; Wang XW; Harris CC
    Int J Cancer; 1999 Mar; 80(6):875-9. PubMed ID: 10074921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
    Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
    Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus X protein inhibits p53-mediated upregulation of mitofusin-2 in hepatocellular carcinoma cells.
    Wang W; Zhou D; Wei J; Wu Z; Cheng X; Sun Q; Xie H; Zhou L; Zheng S
    Biochem Biophys Res Commun; 2012 May; 421(2):355-60. PubMed ID: 22510407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib overcomes the chemoresistance in HBx-expressing hepatocellular carcinoma cells through down-regulation of HBx protein stability and suppresses HBV gene expression.
    Kim HY; Jung HU; Yoo SH; Yoo KS; Cheong J; Park BS; Yun I; Yoo YH
    Cancer Lett; 2014 Dec; 355(1):61-9. PubMed ID: 25218348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells.
    Chung TW; Lee YC; Ko JH; Kim CH
    Cancer Res; 2003 Jul; 63(13):3453-8. PubMed ID: 12839924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.